Results 131 to 140 of about 76,328,651 (141)
Siglec-15 as an Emerging Target for Next-generation Cancer Immunotherapy. [PDF]
Sun J, Lu Q, Sanmamed MF, Wang J.
europepmc +1 more source
Bispecific Siglec-15/T cell antibody (STAB) activates T cells and suppresses pancreatic ductal adenocarcinoma and non-small cell lung tumors in vivo. [PDF]
Shen L +4 more
europepmc +1 more source
Siglec-15/sialic acid axis as a central glyco-immune checkpoint in breast cancer bone metastasis. [PDF]
Wang Y +11 more
europepmc +1 more source
Immunosuppressive checkpoint Siglec-15: a vital new piece of the cancer immunotherapy jigsaw puzzle
Xiubao Ren
doaj +1 more source
Siglec-15 on macrophages suppress the immune microenvironment in patients with PD-L1 negative non-metastasis lung adenocarcinoma. [PDF]
Huang Z +7 more
europepmc +1 more source
Siglec-15 regulates cell proliferation, migration and invasion in bladder cancer
Han-Yuan Gao, Guang-Jian Liu, Yan-Ru Qiu
doaj +1 more source

